Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00450554
Status:
COMPLETED
Last Update Posted:
2012-03-27
First Post:
2007-03-19
Brief Title:
Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac
Sponsor:
University Hospital Rouen
Organization:
University Hospital Rouen
Study Overview
Official Title:
EVALUATION DE LA REPONSE IMMUNITAIRE CONTRE LA SOUCHE DE NEISSERIA MENINGITIDIS B14P1716
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objective of the study is to estimate the proportion of children born between the 01012002 and the 0623200 living around Dieppe cantons Dieppe est Dieppe Ouest and Offranville vaccinated by MenBVac with a serum bactericidal activity against B14P1-716 clone related to a protection 4 before and after the third MenBvac vaccination
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None